NCT05737173View on ClinicalTrials.gov

Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

September 1, 2022

Study Completion Date

October 1, 2022

Conditions
Osteo Arthritis Knee
Interventions
DRUG

Leukocyte-rich platelet-rich plasma

Intra-articular knee injection

DRUG

Leukocyte-poor platelet-rich plasma

Intra-articular knee injection

DRUG

Corticosteroid

Intra-articular knee injection

Trial Locations (1)

20110

Queen Savang Vadhana Memorial Hospital, Si Racha

All Listed Sponsors
lead

Queen Savang Vadhana Memorial Hospital, Thailand

OTHER

NCT05737173 - Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter